FL_genes
| Gene | Tier | Relevant references |
|---|---|---|
| ACTB | 1, aSHM | Lohr et al. 2012 |
| ARID1A | 1 | Love et al. 2012; Krysiak et al. 2017; Zhang et al. 2013 |
| ATP6AP1 | 1 | Okosun et al. 2016 |
| ATP6V1B2 | 1 | Okosun et al. 2016 |
| B2M | 1 | Pararajalingam et al. 2020; Morin et al. 2011 |
| BCL2 | 1, aSHM | Tanaka et al. 1992; Morin et al. 2011; Burkhardt et al. 2022 |
| BCL6 | 1, aSHM | Morin et al. 2011; Love et al. 2012 |
| BCL7A | 1, aSHM | Arthur et al. 2018; Grande et al. 2019; Krysiak et al. 2017 |
| BIRC6 | 1 | Reddy et al. 2017 |
| BTG1 | 1, aSHM | Burkhardt et al. 2022; Morin et al. 2011 |
| BTG2 | 1, aSHM | Love et al. 2012; Morin et al. 2011 |
| BTK | 1 | Krysiak et al. 2017; Albuquerque et al. 2017 |
| CARD11 | 1 | Lenz et al. 2008; Morin et al. 2011; Panea et al. 2019; Wu et al. 2016 |
| CCND3 | 1 | Morin et al. 2011; Richter et al. 2012 |
| CD83 | 1, aSHM | Panea et al. 2019; Russler-Germain et al. 2023; Morin et al. 2013 |
| CREBBP | 1 | Love et al. 2012; Laura Pasqualucci, Dominguez-Sola, et al. 2011 |
| CTSS | 1 | Bararia et al. 2020 |
| DTX1 | 1, aSHM | Panea et al. 2019; Schmitz et al. 2018 |
| EBF1 | 1, aSHM | Bohle et al. 2013; Thomas et al. 2023 |
| EEF1A1 | 1 | Hübschmann et al. 2021 |
| EP300 | 1 | Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019 |
| EZH2 | 1 | Love et al. 2012; Morin et al. 2010 |
| FAS | 1 | Scholl et al. 2007 |
| FOXO1 | 1 | Morin et al. 2011; Schmitz et al. 2012 |
| GNA13 | 1 | Morin et al. 2011; Love et al. 2012 |
| GNAI2 | 1 | Morin et al. 2013; Grande et al. 2019 |
| HIST1H1B | 1, aSHM | Chapuy et al. 2018; Krysiak et al. 2017 |
| HIST1H1C | 1, aSHM | Morin et al. 2011; Panea et al. 2019 |
| HIST1H1D | 1, aSHM | Morin et al. 2013; Krysiak et al. 2017 |
| HIST1H1E | 1, aSHM | Grande et al. 2019; Morin et al. 2013; Krysiak et al. 2017 |
| HIST1H2AC | 1, aSHM | Morin et al. 2013; Krysiak et al. 2017 |
| HIST1H2AG | 1, aSHM | Morin et al. 2013; Krysiak et al. 2017; Panea et al. 2019 |
| HIST1H2AM | 1, aSHM | Krysiak et al. 2017; Panea et al. 2019 |
| HIST1H2BC | 1, aSHM | Krysiak et al. 2017; Reddy et al. 2017 |
| HIST1H2BD | 1, aSHM | Krysiak et al. 2017 |
| HIST1H2BG | 1, aSHM | Krysiak et al. 2017 |
| HIST1H3B | 1, aSHM | Zhang et al. 2013 |
| HIST1H3G | 1, aSHM | Krysiak et al. 2017 |
| HVCN1 | 1 | Krysiak et al. 2017 |
| IRF4 | 1, aSHM | Morin et al. 2011 |
| IRF8 | 1, aSHM | Morin et al. 2011; Panea et al. 2019 |
| ITPKB | 1 | Schmitz et al. 2018 |
| KLF2 | 1, aSHM | Laura Pasqualucci, Trifonov, et al. 2011 |
| KLHL6 | 1, aSHM | Panea et al. 2019; Morin et al. 2011 |
| KMT2D | 1 | Morin et al. 2011; Beà et al. 2013; Grande et al. 2019 |
| LTB | 1, aSHM | Panea et al. 2019; Chapuy et al. 2018 |
| MAP2K1 | 1 | Louissaint et al. 2016; Shin et al. 2015 |
| MEF2B | 1, aSHM | Beà et al. 2013; Morin et al. 2011 |
| MEF2C | 1, aSHM | Arthur et al. 2018 |
| PCLO | 1 | Lohr et al. 2012 |
| PIM1 | 1, aSHM | L. Pasqualucci et al. 2001; Burkhardt et al. 2022 |
| POU2AF1 | 1 | Krysiak et al. 2017 |
| POU2F2 | 1 | Krysiak et al. 2017; Zhang et al. 2013 |
| PTPRD | 1 | |
| RRAGC | 1 | Okosun et al. 2016 |
| S1PR2 | 1, aSHM | Morin et al. 2011; Muppidi et al. 2014 |
| SGK1 | 1, aSHM | Morin et al. 2011 |
| SMARCA4 | 1 | Richter et al. 2012; Nadeu et al. 2020; Zhang et al. 2013; Krysiak et al. 2017 |
| SOCS1 | 1, aSHM | Morin et al. 2011 |
| STAT6 | 1 | Yildiz et al. 2015 |
| TBL1XR1 | 1 | Mareschal et al. 2016 |
| TMSB4X | 1, aSHM | Albuquerque et al. 2017 |
| TNFAIP3 | 1 | Compagno et al. 2009 |
| TNFRSF14 | 1 | Cheung et al. 2010 |
| TP53 | 1 | Morin et al. 2011; Beà et al. 2013; Wilda et al. 2004 |
| VMA21 | 1 | Hübschmann et al. 2021 |
| Gene | Tier | Relevant references |
|---|---|---|
| ABL2 | 2 | Russler-Germain et al. 2023 |
| ACTG1 | 2, aSHM | Hübschmann et al. 2021 |
| ATP6V1A | 2 | Hübschmann et al. 2021 |
| BCL10 | 2 | Russler-Germain et al. 2023; Morin et al. 2011 |
| CCDC42BPB | 2 | Hübschmann et al. 2021 |
| CD70 | 2 | Russler-Germain et al. 2023; Morin et al. 2011 |
| CD79B | 2 | Panea et al. 2019; Morin et al. 2011 |
| CILP | 2 | Russler-Germain et al. 2023 |
| CPNE8 | 2 | Hübschmann et al. 2021 |
| CXCR4 | 2, aSHM | Khodabakhshi et al. 2012; Krysiak et al. 2017; Panea et al. 2019 |
| CYP2A6 | 2 | Russler-Germain et al. 2023 |
| DDX3X | 2 | Schmitz et al. 2012, 2018 |
| DHX15 | 2 | Hübschmann et al. 2021 |
| DUSP2 | 2, aSHM | Morin et al. 2013 |
| EGR1 | 2 | Krysiak et al. 2017 |
| FZR1 | 2 | Hübschmann et al. 2021 |
| GBP7 | 2 | Russler-Germain et al. 2023 |
| GRM6 | 2 | Russler-Germain et al. 2023 |
| HIST1H2BM | 2, aSHM | Krysiak et al. 2017 |
| HIST1H3I | 2, aSHM | Panea et al. 2019; Krysiak et al. 2017 |
| HLA-B | 2 | |
| HNRNPD | 2 | |
| IGLL5 | 2, aSHM | Panea et al. 2019; Russler-Germain et al. 2023 |
| JUP | 2 | Hübschmann et al. 2021 |
| KIR3DL1 | 2 | Russler-Germain et al. 2023 |
| LAPTM5 | 2 | Hübschmann et al. 2021 |
| MAGEC1 | 2 | Russler-Germain et al. 2023 |
| MAP7D1 | 2 | Russler-Germain et al. 2023 |
| MGEA5 | 2 | Hübschmann et al. 2021 |
| MKI67 | 2 | Russler-Germain et al. 2023; Schmitz et al. 2012 |
| MYC | 2, aSHM | Johnston and Carroll 1992; L. Pasqualucci et al. 2001 |
| MYCBP2 | 2 | Hübschmann et al. 2021 |
| MYD88 | 2 | Ngo et al. 2011 |
| NFKBIA | 2 | Russler-Germain et al. 2023; Lake et al. 2009 |
| OR8H2 | 2 | Russler-Germain et al. 2023 |
| P2RY8 | 2 | Lohr et al. 2012; Muppidi et al. 2014 |
| PDS5B | 2 | Morin et al. 2013; Hübschmann et al. 2021 |
| PPP4C | 2 | Hübschmann et al. 2021 |
| PRKDC | 2 | Hübschmann et al. 2021; Schmitz et al. 2018 |
| PZP | 2 | Russler-Germain et al. 2023 |
| RBM6 | 2 | Hübschmann et al. 2021 |
| SESN1 | 2 | Oricchio et al. 2017 |
| SHROOM3 | 2 | Russler-Germain et al. 2023 |
| SRRM2 | 2 | Morin et al. 2013; Russler-Germain et al. 2023 |
| STAB2 | 2 | Russler-Germain et al. 2023 |
| TMEM30A | 2 | Morin et al. 2011 |
| TPP1 | 2 | Hübschmann et al. 2021 |
| XIRP2 | 2 | Russler-Germain et al. 2023 |
| ZC3H12A | 2 | Arthur et al. 2018 |
| ZNF608 | 2 | Krysiak et al. 2017; Zhang et al. 2013 |
Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal, Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing Knowledge Discovery from Cancer Genomics Data with Galaxy.” GigaScience 6 5: 1–13. https://doi.org/10.1093/gigascience/gix015.
Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide Discovery of Somatic Regulatory Variants in Diffuse Large B-cell Lymphoma.” Nature Communications 9 1: 4001. https://doi.org/10.1038/s41467-018-06354-3.
Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe, Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al. 2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.” Cell Reports 31 5: 107522. https://doi.org/10.1016/j.celrep.2020.107522.
Beà, Sílvia, Rafael Valdés-Mas, Alba Navarro, Itziar Salaverria, David Martín-Garcia, Pedro Jares, Eva Giné, et al. 2013. “Landscape of Somatic Mutations and Clonal Evolution in Mantle Cell Lymphoma.” Proceedings of the National Academy of Sciences 110 45: 18250–55. https://doi.org/10.1073/pnas.1314608110.
Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of Early B-cell Factor 1 EBF1 in Hodgkin Lymphoma.” Leukemia 27 3: 671–79. https://doi.org/10.1038/leu.2012.280.
Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance of Molecular Characteristics in Burkitt Lymphoma Differs According to Age.” Nature Communications 13 1: 3881. https://doi.org/10.1038/s41467-022-31355-8.
Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes.” Nature Medicine 24 5: 679–90. https://doi.org/10.1038/s41591-018-0016-8.
Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. 2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis.” Cancer Research 70 22: 9166–74. https://doi.org/10.1158/0008-5472.CAN-10-2460.
Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of Multiple Genes Cause Deregulation of NF-kappaB in Diffuse Large B-cell Lymphoma.” Nature 459 7247: 717–21. https://doi.org/10.1038/nature07968.
Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019. “Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in Pediatric Endemic and Sporadic Burkitt Lymphoma.” Blood 133 12: 1313–24. https://doi.org/10.1182/blood-2018-09-871418.
Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. 2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of Germinal Center Derived B-cell Lymphomas.” Leukemia 35 7: 2002–16. https://doi.org/10.1038/s41375-021-01251-z.
Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in Burkitt’s Lymphoma.” Leukemia & Lymphoma 8 6: 431–39. https://doi.org/10.3109/10428199209051025.
Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J. Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in Lymphoma.” Oncotarget 3 11: 1308–19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/.
Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. “Recurrent Somatic Mutations Affecting B-cell Receptor Signaling Pathway Genes in Follicular Lymphoma.” Blood 129 4: 473–83. https://doi.org/10.1182/blood-2016-07-729954.
Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical Hodgkin Lymphoma but Are Not a Unifying Feature of Non-EBV-associated Cases.” International Journal of Cancer 125 6: 1334–42. https://doi.org/10.1002/ijc.24502.
Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma.” Science 319 5870: 1676–79.
Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair, Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012. “Discovery and Prioritization of Somatic Mutations in Diffuse Large B-cell Lymphoma DLBCL by Whole-Exome Sequencing.” Proceedings of the National Academy of Sciences of the United States of America 109 10: 3879–84. https://doi.org/10.1073/pnas.1121343109.
Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. “Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct Lymphoma with Frequent MAPK Pathway Mutations.” Blood 128 8: 1093–1100. https://doi.org/10.1182/blood-2015-12-682591.
Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of Mutations in Burkitt Lymphoma.” Nature Genetics 44 12: 1321–25. https://doi.org/10.1038/ng.2468.
Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients Expands the Repertoire of Somatic Mutations in Diffuse Large B-cell Lymphoma.” Genes, Chromosomes & Cancer 55 3: 251–67. https://doi.org/10.1002/gcc.22328.
Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. “Somatic Mutations Altering EZH2 Tyr641 in Follicular and Diffuse Large B-cell Lymphomas of Germinal-Center Origin.” Nature Genetics 42 2: 181–85. https://doi.org/10.1038/ng.518.
Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. “Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” Nature 476 7360: 298–303. https://doi.org/10.1038/nature10351.
Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and Structural Analysis of Diffuse Large B-cell Lymphoma Using Whole-Genome Sequencing.” Blood 122 7: 1256–65. https://doi.org/10.1182/blood-2013-02-483727.
Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao, Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in Germinal Center B Cell-Derived Lymphoma.” Nature 516: 254–58. https://doi.org/10.1038/nature13765.
Nadeu, F., D. Martín-García, G. Clot, A. Díaz-Navarro, M. Duran-Ferrer, A. Navarro, Roser Vilarrasa-Blasi, et al. 2020. “Genomic and Epigenomic Insights into the Origin, Pathogenesis and Clinical Behavior of Mantle Cell Lymphoma Subtypes.” Blood. https://doi.org/10.1182/blood.2020005289.
Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active MYD88 Mutations in Human Lymphoma.” Nature 470 7332: 115–19. https://doi.org/10.1038/nature09671.
Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. “Recurrent mTORC1-activating RRAGC Mutations in Follicular Lymphoma.” Nature Genetics 48 2: 183–88. https://doi.org/10.1038/ng.3473.
Oricchio, Elisa, Natalya Katanayeva, Maria Christine Donaldson, Stephanie Sungalee, Joyce P. Pasion, Wendy Béguelin, Elena Battistello, et al. 2017. “Genetic and Epigenetic Inactivation of SESTRIN1 Controls mTORC1 and Response to EZH2 Inhibition in Follicular Lymphoma.” Science Translational Medicine 9 396: eaak9969. https://doi.org/10.1126/scitranslmed.aak9969.
Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A. Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt Lymphoma Subtypes.” Blood. https://doi.org/10.1182/blood.2019001880.
Pararajalingam, Prasath, Krysta M. Coyle, Sarah E. Arthur, Nicole Thomas, Miguel Alcaide, Barbara Meissner, Merrill Boyle, et al. 2020. “Coding and Noncoding Drivers of Mantle Cell Lymphoma Identified Through Exome and Genome Sequencing.” Blood 136 5: 572–84. https://doi.org/10.1182/blood.2019002385.
Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. “Inactivating Mutations of Acetyltransferase Genes in B-cell Lymphoma.” Nature 471 7337: 189–95. https://doi.org/10.1038/nature09730.
Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of the Coding Genome of Diffuse Large B-cell Lymphoma.” Nature Genetics 43 9: 830–37. https://doi.org/10.1038/ng.892.
Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of Multiple Proto-Oncogenes in B-cell Diffuse Large-Cell Lymphomas.” Nature 412 6844: 341–46. https://doi.org/10.1038/35085588.
Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.” Cell 171 2: 481–494.e15.
Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated Genome, Exome and Transcriptome Sequencing.” Nature Genetics 44 12: 1316–20. https://doi.org/10.1038/ng.2469.
Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. 2023. “Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis: Alliance A151303.” Blood Advances 7: 5524–39. https://doi.org/10.1182/bloodadvances.2023010779.
Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson, James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018. “Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” The New England Journal of Medicine 378 15: 1396–1407. https://doi.org/10.1056/NEJMoa1801445.
Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics.” Nature 490 7418: 116–20. https://doi.org/10.1038/nature11378.
Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector, and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of FAS/CD95 Gene in Nodal Diffuse Large B-cell Lymphoma.” Leukemia & Lymphoma 48 5: 957–63. https://doi.org/10.1080/10428190701230858.
Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases.” Annals of Laboratory Medicine 35 2: 257–59. https://doi.org/10.3343/alm.2015.35.2.257.
Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of Non-Hodgkin’s Lymphomas.” Blood 79 1: 229–37.
Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023. “Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma.” Blood 141 8: 904–16. https://doi.org/10.1182/blood.2022016534.
Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and W. Woessmann. 2004. “Inactivation of the ARF-MDM-2-p53 Pathway in Sporadic Burkitt’s Lymphoma in Children.” Leukemia 18 3: 584–88. https://doi.org/10.1038/sj.leu.2403254.
Wu, Chenglin, Noel Fcc de Miranda, Longyun Chen, Agata M. Wasik, Larry Mansouri, Wojciech Jurczak, Krystyna Galazka, et al. 2016. “Genetic Heterogeneity in Primary and Relapsed Mantle Cell Lymphomas: Impact of Recurrent CARD11 Mutations.” Oncotarget 7 25: 38180–90. https://doi.org/10.18632/oncotarget.9500.
Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 Mutations in Follicular Lymphoma.” Blood 125 4: 668–79. https://doi.org/10.1182/blood-2014-06-582650.
Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. “Genetic Heterogeneity of Diffuse Large B-cell Lymphoma.” January.
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.